VIRAHEP-C: A STUDY OF ANTIVIRAL RESISTANCE IN AFR AMER/CAUCASIAN-HEP C

该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子项目和研究者（PI）可能从另一个NIH来源获得主要资金，因此可以在其他CRISP条目中表示。所列机构为中心机构，不一定为研究者机构。本研究的目的是测试这种药物的安全性和有效性，并比较非洲裔美国人和白人丙型肝炎患者对抗病毒治疗反应的差异，并了解为什么反应可能存在差异。此外，在常规研究访视期间获得的血液样本也将用于特殊丙型肝炎检测的额外研究，以检查为什么有些患者对治疗无反应。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to test the safety and effectiveness of this medication, and to compare differences in how African American and Caucasian patients with hepatitis C respond to antiviral therapy and to learn why there may be differences in response. In addition, blood samples that will be obtained during the regular study visits will also be used for additional studies for special hepatitis C testing to examine why some patients do not respond to treatment.